Cipla and Ranbaxy are showing strength: Edelweiss

Jitendra Mehta, technical analyst, Edelweiss, in a chat with ET Now talks about Strides Arcolab or an Aurobindo Pharma.

Have you looked at Strides Arcolab or an Aurobindo Pharma?

Yeah. I looked at this healthcare space. Even Cipla and Ranbaxy were showing some strength but then Aurobindo has just got confined in a trading range and it will take some time for it to just break out of this. So with 920-930 range, that has been pretty much there.

Strides Arcolab I have not tracked so regularly but then there was some kind of a breakout in last few trading sessions but then it just came down below that. So have not traded so aggressively to put out clear levels there.